Search research articles
Contact Us
Filters
Showing results (31-40 of 103) with videos related to
Page
of 11
Sort By:
Anticancer Research
|
November 1, 1992
Ly-6A/E gene is widely expressed among transformed nonhematopoietic cells. Autocrine modulation by interferon
P L Lollini, L Landuzzi, G Nicoletti, et al.
British Journal of Cancer
|
September 1, 1992
Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon
P Nanni, L Landuzzi, G Nicoletti, et al.
Invasion & Metastasis
|
January 1, 1992
Induction of invasive and experimental metastasis potential in BALB/c 3T3 cells by benzo(a)pyrene transformation
A Melchiori, A Colacci, P L Lollini, et al.
International Journal of Cancer
|
October 15, 1994
H-2Kb and H-2Db gene transfections in B16 melanoma differently affect non-immunological properties relevant to the metastatic process. Involvement of integrin molecules
C De Giovanni, G Nicoletti, M Sensi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2001
An anti-apoptotic role for NGF receptors in human rhabdomyosarcoma
A Astolfi, P Nanni, L Landuzzi, et al.
Scandinavian Journal of Immunology
|
March 1, 1992
TNF impairs in vivo and in vitro natural killer (NK) susceptibility of B16 melanoma cells
G Palmieri, S Morrone, P L Lollini, et al.
Cancer Research
|
July 1, 1989
Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs
P L Lollini, C De Giovanni, B Del Re, et al.
Anticancer Research
|
March 1, 1993
Establishment and characterization of multidrug-resistant human osteosarcoma cell lines
M Serra, K Scotlandi, M C Manara, et al.
The American Journal of Pathology
|
May 11, 1999
Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response
C Rozera, D Carlei, P L Lollini, et al.
Clinical & Experimental Metastasis
|
March 1, 1990
Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma
P L Lollini, C De Giovanni, G Nicoletti, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 103) with videos related to
Sort By:
Page
of 11
Anticancer Research
|
November 1, 1992
Ly-6A/E gene is widely expressed among transformed nonhematopoietic cells. Autocrine modulation by interferon
P L Lollini, L Landuzzi, G Nicoletti, et al.
British Journal of Cancer
|
September 1, 1992
Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon
P Nanni, L Landuzzi, G Nicoletti, et al.
Invasion & Metastasis
|
January 1, 1992
Induction of invasive and experimental metastasis potential in BALB/c 3T3 cells by benzo(a)pyrene transformation
A Melchiori, A Colacci, P L Lollini, et al.
International Journal of Cancer
|
October 15, 1994
H-2Kb and H-2Db gene transfections in B16 melanoma differently affect non-immunological properties relevant to the metastatic process. Involvement of integrin molecules
C De Giovanni, G Nicoletti, M Sensi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2001
An anti-apoptotic role for NGF receptors in human rhabdomyosarcoma
A Astolfi, P Nanni, L Landuzzi, et al.
Scandinavian Journal of Immunology
|
March 1, 1992
TNF impairs in vivo and in vitro natural killer (NK) susceptibility of B16 melanoma cells
G Palmieri, S Morrone, P L Lollini, et al.
Cancer Research
|
July 1, 1989
Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs
P L Lollini, C De Giovanni, B Del Re, et al.
Anticancer Research
|
March 1, 1993
Establishment and characterization of multidrug-resistant human osteosarcoma cell lines
M Serra, K Scotlandi, M C Manara, et al.
The American Journal of Pathology
|
May 11, 1999
Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response
C Rozera, D Carlei, P L Lollini, et al.
Clinical & Experimental Metastasis
|
March 1, 1990
Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma
P L Lollini, C De Giovanni, G Nicoletti, et al.
Page
of 11